KITLG and Alzheimer disease: The findings of this study provide the unbiased identification of SCF+G-CSF treatment-related transcriptional profiles of immune cells in the brain, which may guide future mechanistic studies to understand how SCF+G-CSF treatment mitigates AD pathology.